Secretory Endometrial Adenocarcinoma in a Tamoxifen User With Breast Cancer After Menopause

Secretory Endometrial Adenocarcinoma in a Tamoxifen User With Breast Cancer After Menopause

Bibliographic Details
Main Authors:	Chia-Jen Wu, Yi-Jen Peng, Mu-Hsien Yu, Chi-Huang Chen
Format:	Article
Language:	English
Published:	Elsevier 2007-03-01
Series:	Taiwanese Journal of Obstetrics & Gynecology
Online Access:	http://www.sciencedirect.com/science/article/pii/S1028455908601187

Similar Items

Tamoxifen and endometrial cancer risk among breast cancer patients in Taiwan
by: Lee, Hsin-Yi, et al.
Published: (2018)

Endometrial ablation for prevention of recurrent endometrial pathology in postmenopausal breast cancer patients receiving tamoxifen
by: I O Mamikonyan, et al.
Published: (2015-02-01)

Tamoxifen-induced endometrial carcinoma after a lag of 14 years
by: Anil Kumar Dhull, et al.
Published: (2013-01-01)

Risk of Endometrial Cancer and Frequencies of Invasive Endometrial Procedures in Young Breast Cancer Survivors Treated With Tamoxifen: A Nationwide Study
by: Soojeong Choi, et al.
Published: (2021-06-01)

Tamoxifen and Endometrial Cancer: A Janus-Headed Drug
by: Günter Emons, et al.
Published: (2020-09-01)

Low ERK phosphorylation in cancer-associated fibroblasts is associated with tamoxifen resistance in pre-menopausal breast cancer.
by: Susann Busch, et al.
Published: (2012-01-01)

Features of ultrasound of endometrial pathological conditions in breast cancer patients receiving tamoxifen: a review of literature
by: M. A. Chekalova, et al.
Published: (2020-06-01)

Tamoxifen for Breast Cancer
by: A Karn, et al.
Published: (2010-03-01)

Secretory carcinoma of the breast: A case report and literature review
by: I-Kai Wu, et al.
Published: (2021-01-01)

Resuming Sensitivity of Tamoxifen-Resistant Breast Cancer Cells to Tamoxifen by Tetrandrine
by: Yuntao Wang MS, et al.
Published: (2021-03-01)

Combination treatment of tamoxifen with risperidone in breast cancer.
by: Wei-Lan Yeh, et al.
Published: (2014-01-01)

A Reconsideration Of Tamoxifen Use for Breast Cancer
by: Peng-Hui Wang, et al.
Published: (2007-06-01)

Synchronous endometrial adenocarcinoma and carcinosarcoma in endometrial polyp
by: Yanal Alnimer, et al.
Published: (2018-05-01)

Uterine Carcinosarcoma Associated with Tamoxifen Use in a Menopausal ‎Patient: A Case Report ‎
by: T Ashrafganjoei, et al.
Published: (2015-12-01)

Morphological markers of secretory activity in prostatic adenocarcinoma
by: Janković-Veličković Ljubinka, et al.
Published: (2007-01-01)

Studies of tamoxifen resistance in breast cancer
by: Palmebäck Wegman, Pia
Published: (2007)

Mechanism of tamoxifen resistance in breast cancer
by: Shah, Khyati Niral
Published: (2014)

Menopausal hot flushes after breast cancer
by: Fenlon, D.R, et al.
Published: (2009)

Inhibition of STAT3 enhances sensitivity to tamoxifen in tamoxifen-resistant breast cancer cells
by: Seo Yun Moon, et al.
Published: (2021-08-01)

Menopause, breast cancer and menopausal treatments
by: Antoine, Caroline
Published: (2018)

Microarray Analysis on Gene Regulation by Estrogen, Progesterone and Tamoxifen in Human Endometrial Stromal Cells
by: Chun-E Ren, et al.
Published: (2015-03-01)

Age at Menopause and Risk of Developing Endometrial Cancer: A Meta-Analysis
by: Yanjun Wu, et al.
Published: (2019-01-01)

Rac1 Regulates Endometrial Secretory Function to Control Placental Development.
by: Juanmahel Davila, et al.
Published: (2015-08-01)

The Effects of Secretory Lcn2 Protein on Mouse Primary Endometrial Epithelium.
by: Yan-Tzu Chen, et al.
Published: (2010)

Basal cell adenocarcinoma of the supraglottic larynx: treatment of recurrent disease with tamoxifen
by: Glen J. Weiss, et al.
Published: (2011-10-01)

Radiation-induced circumscribed superficial morphea after brachytherapy for endometrial adenocarcinoma
by: Apoorva Trivedi, BS, et al.
Published: (2017-12-01)

The use of tamoxifen in the treatment and prevention of breast cancer
by: Magdalena Hołowczuk, et al.
Published: (2019-06-01)

Early and late tamoxifen resistance in breast cancer
by: Abu Rabi Z., et al.
Published: (2010-01-01)

Effects of sex steroids and tamoxifen on VEGF in the breast
by: Garvin, Stina
Published: (2006)

The benefits and costs of tamoxifen for breast cancer prevention
by: Simon D. Eckermann, et al.
Published: (2003-02-01)

Tamoxifen for women at high risk of breast cancer
by: Nazarali SA, et al.
Published: (2014-02-01)

Putative biomarkers of tamoxifen response in breast cancer
by: Keilty, Dana
Published: (2011)

The Tamoxifen Adherence with Breast Cancer Patients in Taiwan
by: Wang, Fong-Chin, et al.
Published: (2011)

Microarray analysis of tamoxifen resistance in breast cancer
by: Moss, Charlotte
Published: (2009)

The differences in RCAS1 and DFF45 endometrial expression between late proliferative, early secretory, and mid-secretory cycle phases.
by: Jaroslaw Kalinka, et al.
Published: (2008-04-01)

The differences in RCAS1 and DFF45 endometrial expression between late proliferative, early secretory, and mid-secretory cycle phases.
by: Jerzy Sikora, et al.
Published: (2008-04-01)

Endocrine Risk Factors of Endometrial Cancer: Polycystic Ovary Syndrome, Oral Contraceptives, Infertility, Tamoxifen
by: Atanas Ignatov, et al.
Published: (2020-07-01)

The agonist activity of the antioestrogens tamoxifen and ICI 164, 384 in the human endometrial cell line ishikawa
by: Astle, Shirley
Published: (2001)

Cytodiagnosis of secretory carcinoma of the breast
by: Vissa Shanthi, et al.
Published: (2012-01-01)

Identification of genes associated with the maintenance of the tamoxifen resistant breast cancer cell phenotype following tamoxifen withdrawal
by: Stone, Andrew
Published: (2008)

Cannot write session to /tmp/vufind_sessions/sess_2gs6oeledicb18c1iqhsqa3b2d